Topology and dynamics of signaling networks: In search of transcriptional control of the inflammatory response

Annual Review of Biomedical Engineering

Volumn 15, Issue , 2013, Pages 1-28

  Androulakis, Ioannis P ^a,b   Kamisoglu, Kubra ^a   Mattick, John S ^a  

^a The State University of New Jersey   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

computational modeling; inflammation; phosphoproteins; proteomics; signal transduction

Indexed keywords

COMPUTATIONAL MODELING; COMPUTATIONAL TECHNIQUE; INFLAMMATION; INFLAMMATORY RESPONSE; PHOSPHOPROTEINS; PROTEOMICS; TRANSCRIPTIONAL ACTIVITY; TRANSCRIPTIONAL CONTROL;

MOLECULAR BIOLOGY; SIGNAL TRANSDUCTION; SIGNALING;

PROTEINS;

CARRIER PROTEIN; CELL PROTEIN; CELL SURFACE MARKER; DUAL SPECIFICITY PHOSPHATASE; I KAPPA B KINASE INHIBITOR; LIPOPOLYSACCHARIDE; PHOSPHOPROTEIN; STREPTAVIDIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRANULOCYTIC LEUKEMIA; ADIPOSE TISSUE; ALZHEIMER DISEASE; ANTIBODY LABELING; APOPTOSIS; ARTHRITIS; ATHEROSCLEROSIS; CANCER GROWTH; CELL FUNCTION; CELL LYSATE; CELL PROLIFERATION; CELL STRAIN HEPG2; CELL SUBPOPULATION; CELL TRANSFORMATION; CELLULAR DISTRIBUTION; CLINICAL PATHWAY; COLON CANCER; COLUMN CHROMATOGRAPHY; CROSS REACTION; DIABETES MELLITUS; DYNAMICS; ELECTROBLOTTING; ELECTROSPRAY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXPERIMENTAL DESIGN; FEEDBACK SYSTEM; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; FOLLOW UP; FUZZY LOGIC; GEL ELECTROPHORESIS; GENE REGULATORY NETWORK; HOMEOSTASIS; HUMAN; IMMUNOBLOTTING; IMMUNOPHENOTYPING; IMMUNOSURVEILLANCE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; INFLAMMATORY CELL; INNATE IMMUNITY; INSULIN RESISTANCE; INTRACELLULAR SIGNALING; LIGHT SCATTERING; LIQUID CHROMATOGRAPHY; LIVER BIOPSY; LIVER CELL CARCINOMA; MASS ACTION; MASS SPECTROMETRY; MOLECULAR PROBE; MOLECULAR WEIGHT; NONALCOHOLIC FATTY LIVER; OBESITY; PARALLEL DESIGN; PHENOTYPE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN MICROARRAY; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; PROTEOMICS; RESPIRATORY TRACT INFLAMMATION; REVIEW; SAMPLE SIZE; SEPARATION TECHNIQUE; SIGNAL DETECTION; STUDY DESIGN; SYSTEMS BIOLOGY; WESTERN BLOTTING; WILD TYPE;

ANIMALS; APOPTOSIS; BAYES THEOREM; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; CYTOKINES; FLUORESCENT DYES; GENE REGULATORY NETWORKS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MASS SPECTROMETRY; PROTEIN ARRAY ANALYSIS; PROTEOMICS; REGRESSION ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84880550422     PISSN: 15239829     EISSN: 15454274     Source Type: Book Series    
DOI: 10.1146/annurev-bioeng-071812-152425     Document Type: Review

References (107)

1. Laroux FS. 2004. Mechanisms of inflammation: The good, the bad and the ugly. Front. Biosci. 9:3156-62
2. Bone RC. 1996. Immunologic dissonance: A continuing evolution in our understanding of the systemic inflammatory response syndrome (SIRS) and the multiple organ dysfunction syndrome (MODS). Ann. Intern. Med. 125:680-87
3. Mi Q, Li N, ZiraldoC,Ghuma A, Mikheev M, et al. 2010. Translational systems biology of inflammation: Potential applications to personalized medicine. Personalized Med. 7:549-59
4. Nathan C. 2002. Points of control in inflammation. Nature 420:846-52
5. Flajnik MF, Du Pasquier L 2004. Evolution of innate and adaptive immunity: Can we draw a line? Trends Immunol. 25:640-44
6. Chow CC, Clermont G, Kumar R, Lagoa C, Tawadrous Z, et al. 2005. The acute inflammatory response in diverse shock states. Shock 24:74-84
7. TorresA,Bentley T, Bartels J, Sarkar J,Barclay D, et al. 2009. Mathematical modeling of posthemorrhage inflammation in mice: Studies using a novel, computer-controlled, closed-loop hemorrhage apparatus. Shock 32:172-78
8. Foteinou P, Calvano S, Lowry S, Androulakis I. 2009. Modeling endotoxin-induced systemic inflammation using an indirect response approach. Math. Biosci. 217:27-42
9. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. 2009. In silico simulation of corticosteroids effect on an NFkB-Dependent physicochemical model of systemic inflammation. PLoS ONE 4:e4706
10. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. 2010. Multiscale model for the assessment of autonomic dysfunction in human endotoxemia. Physiol. Genomics 42:5-19
11. Vodovotz Y, Csete M, Bartels J, Chang S, An G. 2008. Translational systems biology of inflammation. PLoS Comput. Biol. 4:e1000014
12. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. 2011. A physiological model for autonomic heart rate regulation in human endotoxemia. Shock 35:229-39
13. Nguyen A, YaffeMB. 2003. Proteomics and systems biology approaches to signal transduction in sepsis. Crit. Care Med. 31(Suppl. 1):S1-6
14. Cravatt BF, Simon GM, Yates JR III. 2007. The biological impact of mass-spectrometry-based proteomics. Nature 450:991-1000
15. Aebersold R, Mann M. 2003. Mass spectrometry-based proteomics. Nature 422:198-207
16. Terfve C, Saez-Rodriguez J. 2012. Modeling signaling networks using high-Throughput phosphoproteomics. In Advances in Systems Biology, ed. II Goryanin, AB Goryachev, pp. 19-57. New York: Springer
17. Rosenqvist H, Ye J, Jensen O. 2010. Analytical strategies in mass spectrometry-based phosphoproteomics. Methods Mol. Biol. 753:183-213
18. Yates JR, Ruse CI, Nakorchevsky A. 2009. Proteomics by mass spectrometry: Approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11:49-79
19. Weintz G, Olsen JV, Fr ühauf K, Niedzielska M, Amit I, et al. 2010. The phosphoproteome of toll-like receptor-Activated macrophages. Mol. Syst. Biol. 6:371
20. Stasyk T, Huber LA. 2012. Mapping in vivo signal transduction defects by phosphoproteomics. Trends Mol. Med. 18:43-51
21. Millward SW,Henning RK,Kwong GA, Pitram S, AgnewHD, et al. 2011. Iterative in situ click chemistry assembles a branched capture agent and allosteric inhibitor for Akt1. J. Am. Chem. Soc. 133:18280-88
22. Kurien BT, Dorri Y, Dillon S, Dsouza A, Scofield RH. 2011. An overview of Western blotting for determining antibody specificities for immunohistochemistry. Methods Mol. Biol. 717:55-67
23. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-85
24. Thornton DJ, Carlstedt I, Sheehan JK. 1996. Identification of glycoproteins on nitrocellulose membranes and gels. Mol. Biotechnol. 5:171-76
25. Ciaccio MF, Wagner JP, Chuu C-P, Lauffenburger DA, Jones RB. 2010. Systems analysis of EGF receptor signaling dynamics with microwestern arrays. Nat. Meth. 7:148-55
26. Archuleta AJ, Stutzke CA, Nixon KM, Browning MD. 2011. Optimized protocol to make phosphospecific antibodies that work. Methods Mol. Biol. 717:69-88
27. Karrasch T, Spaeth T, Allard B, Jobin C. 2011. PI3K-Dependent GSK3β(Ser9)-phosphorylation is implicated in the intestinal epithelial cell wound-healing response. PLoS One 6:e26340
28. Andreasen AS, Kelly M, Berg RM, Moller K, Pedersen BK. 2011. Type 2 diabetes is associated with altered NF-κB DNA binding activity, JNK phosphorylation, and AMPK phosphorylation in skeletal muscle after LPS. PLoS One 6:e23999
29. Cho YE, SinghTS, LeeHC, Moon PG, Lee JE, et al. 2012. In-Depth identification of pathways related to cisplatin-induced hepatotoxicity through an integrative method based on an informatics-Assisted labelfree protein quantitation and microarray gene expression approach. Mol. Cell. Proteomics 11:M111.010884
30. Basu S, Campbell HM, Dittel BN, Ray A. 2010. Purification of specific cell population by fluorescence activated cell sorting (FACS). J. Vis. Exp. e1546
31. Perfetto SP, Chattopadhyay PK, Roederer M. 2004. Seventeen-colour flow cytometry: Unravelling the immune system. Nat. Rev. Immunol. 4:648-55
32. Perez OD, Nolan GP. 2006. Phospho-proteomic immune analysis by flow cytometry: From mechanism to translational medicine at the single-cell level. Immunol. Rev. 210:208-28
33. Irish JM, Hovland R, Krutzik PO, Perez OD, Bruserud Ø, et al. 2004. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118:217-28
34. Irish JM, Kotecha N, Nolan GP. 2006. Mapping normal and cancer cell signalling networks: Towards single-cell proteomics. Nat. Rev. Cancer 6:146-55
35. Sachs K, Perez O, Pe'er D, Lauffenburger DA, Nolan GP. 2005. Causal protein-signaling networks derived from multiparameter single-cell data. Science 308:523-29
36. Yu X, Schneiderhan-Marra N, Hsu H-Y, Bachmann J, Joos TO. 2009. Protein microarrays: Effective tools for the study of inflammatory diseases. Methods Mol. Biol. 577:199-214
37. Calvert VS, Collantes R, ElarinyH, Afendy A, Baranova A, et al. 2007. A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis. Hepatology 46:166-72
38. Luckert K, Gujral TS, Chan M, Sevecka M, Joos TO, et al. 2012. A dual array-based approach to assess the abundance and posttranslational modification state of signaling proteins. Sci. Signal. 5:pl1; Erratum. 2012. Sci. Signal. 5:er5
39. Alexopoulos LG, Saez-Rodriguez J, Cosgrove BD, Lauffenburger DA, Sorger PK. 2010. Networks inferred from biochemical data reveal profound differences in TLR and inflammatory signaling between normal and transformed hepatocytes. Mol. Cell. Proteomics 9:1849-65
40. Melas IN,Mitsos A,Messinis DE, Weiss TS, Alexopoulos LG. 2011. Combined logical and data-Driven models for linking signalling pathways to cellular response. BMC Syst. Biol. 5:107
41. Saez-Rodriguez J, Alexopoulos LG, Epperlein J, Samaga R, Lauffenburger DA, et al. 2009. Discrete logic modelling as a means to link protein signalling networks with functional analysis of mammalian signal transduction. Mol. Syst. Biol. 5:331
42. Janes KA, Albeck JG, Peng LX, Sorger PK, Lauffenburger DA, Yaffe MB. 2003. A high-Throughput quantitative multiplex kinase assay for monitoring information flow in signaling networks: Application to sepsis-Apoptosis. Mol. Cell. Proteomics 2:463-73
43. Miller-Jensen K, Janes KA, Brugge JS, Lauffenburger DA. 2007. Common effector processing mediates cell-specific responses to stimuli. Nature 448:604-8
44. Calvano SE, Xiao W, Richards DR, Felciano RM, Baker HV, et al. 2005. A network-based analysis of systemic inflammation in humans. Nature 437:1032-37
45. Lissauer ME, Johnson SB, Bochicchio GV, Feild CJ, Cross AS, et al. 2009. Differential expression of toll-like receptor genes: Sepsis compared with sterile inflammation 1 day before sepsis diagnosis. Shock 31:238-44
46. Amirian ES, ScheurerME, Liu Y,D'Amelio AM,Houlston RS, et al. 2011. A novel approach to exploring potential interactions among single-nucleotide polymorphisms of inflammation genes in gliomagenesis: An exploratory case-only study. Cancer Epidemiol. Biomark. Prev. 20:1683-89
47. Ng A, Bursteinas B, Gao Q, Mollison E, Zvelebil M. 2006. pSTIING: A 'systems' approach towards integrating signalling pathways, interaction and transcriptional regulatory networks in inflammation and cancer. Nucleic Acids Res. 34:D527-34
48. Nguyen TT, Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. 2011. Computational identification of transcriptional regulators in human endotoxemia. PLoS ONE 6:e18889
49. Aldridge BB, Saez-Rodriguez J, Muhlich JL, Sorger PK, Lauffenburger DA. 2009. Fuzzy logic analysis of kinase pathway crosstalk in TNF/EGF/insulin- induced signaling. PLoS Comput. Biol. 5:e1000340
50. Chen WW, Schoeberl B, Jasper PJ, Niepel M, Nielsen UB, et al. 2009. Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data. Mol. Syst. Biol. 5:239
51. Zanon M, Riz M, Sparacino G, Facchinetti A, Suri RE, et al. 2011. Assessment of linear regression techniques for modeling multisensor data for non-invasive continuous glucose monitoring. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2011:2538-41
52. Schneider A, Hommel G, Blettner M. 2010. Linear regression analysis: Part 14 of a series on evaluation of scientific publications. Dtsch. Arztebl. Int. 107:776-82
53. Thomas S, Bonchev D. 2010. A survey of current software for network analysis in molecular biology. Hum. Genomics 4:353-60
54. Nelander S,WangW, Nilsson B, She QB, Pratilas C, et al. 2008. Models from experiments: Combinatorial drug perturbations of cancer cells. Mol. Syst. Biol. 4:216
55. Alexopoulos LG, Saez-Rodriguez J, Espelin CW. 2008. High-Throughput protein-based technologies and computational models for drug development, efficacy, and toxicity. In Drug Efficacy, Safety, and Biologics Discovery: Emerging Technologies and Tools, ed. S Ekins, JJ Xu, pp. 29-52. Hoboken, NJ: John Wiley & Sons
56. Chi H, Barry SP, Roth RJ, Wu JJ, Jones EA, et al. 2006. Dynamic regulation of pro-And antiinflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc. Natl. Acad. Sci. USA 103:2274-79
57. McDunn JE, Husain KD, Polpitiya AD, Burykin A, Ruan J, et al. 2008. Plasticity of the systemic inflammatory response to acute infection during critical illness: Development of the riboleukogram. PLoS One 3:e1564
58. Yoshimura A, Naka T, Kubo M. 2007. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7:454-65
59. Gaudet S, Janes KA, Albeck JG, Pace EA, Lauffenburger DA, Sorger PK. 2005. A compendium of signals and responses triggered by prodeath and prosurvival cytokines. Mol. Cell. Proteomics 4:1569-90
60. Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB. 2005. A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis. Science 310:1646-53
61. Levy DE, Lee CK. 2002. What does Stat3 do? J. Clin. Invest. 109:1143-48
62. Orman MA, Nguyen TT, Ierapetritou MG, Berthiaume F, Androulakis IP. 2011. Comparison of the cytokine and chemokine dynamics of the early inflammatory response in models of burn injury and infection. Cytokine 55:362-71
63. Finbloom DS, Winestock KD. 1995. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J. Immunol. 155:1079-90
64. Aldridge BB, Burke JM, Lauffenburger DA, Sorger PK. 2006. Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 8:1195-203
65. Vodovotz Y, Chow CC, Bartels J, Lagoa C, Prince JM, et al. 2006. In silico models of acute inflammation in animals. Shock 26:235-44
66. Feuerstein G, Hallenbeck JM, Vanatta B, Rabinovici R, Perera PY, Vogel SN. 1990. Effect of gramnegative endotoxin on levels of serum corticosterone,TNFalpha, circulating blood cells, and the survival of rats. Circ. Shock 30:265-78
67. Conzelmann H, Saez-Rodriguez J, Sauter T, Kholodenko BN, Gilles ED. 2006. A domain-oriented approach to the reduction of combinatorial complexity in signal transduction networks. BMC Bioinformatics 7:34
68. Birtwistle MR, Kholodenko BN. 2009. Endocytosis and signalling: A meeting with mathematics. Mol. Oncol. 3:308-20
69. Huang CY, Ferrell JE Jr. 1996. Ultrasensitivity in the mitogen-Activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 93:10078-83
70. Pearl J. 1988. Probabilistic Reasoning in Intelligent Systems: Networks of Plausible Inference. San Francisco: Morgan Kaufmann
71. Mukherjee S, Speed TP. 2008. Network inference using informative priors. Proc. Natl. Acad. Sci. 105:14313-18
72. de Jong H. 2002. Modeling and simulation of genetic regulatory systems: A literature review. J. Comput. Biol. 9:67-103
73. OsuchowskiMF, Welch K, Siddiqui J, Remick DG. 2006. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality. J. Immunol. 177:1967-74
74. Kyriakis JM, Avruch J. 2001. Mammalian mitogen-Activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807-69
75. Kauffman S. 1969. Homeostasis and differentiation in random genetic control networks. Nature 224:177-78
76. Watterson S, Marshall S, Ghazal P. 2008. Logic models of pathway biology. Drug Discov. Today 13:447-56
77. MorrisMK, Saez-Rodriguez J, Sorger PK, Lauffenburger DA. 2010. Logic-basedmodels for the analysis of cell signaling networks. Biochemistry 49:3216-24
78. Lin CT, Lee CSG. 1991. Neural-network-based fuzzy logic control and decision system. Comput. IEEE Trans. 40:1320-36
79. Rothwarf DM, Karin M. 1999. TheNF-κB activation pathway: A paradigm in information transfer from membrane to nucleus. Sci. STKE 1999:re1
80. Morris MK, Saez-Rodriguez J, Clarke DC, Sorger PK, Lauffenburger DA. 2011. Training signaling pathwaymaps to biochemical data with constrained fuzzy logic: Quantitative analysis of liver cell responses to inflammatory stimuli. PLoS Comput. Biol. 7:e1001099
81. Saez-Rodriguez J, Alexopoulos LG, Zhang M, MorrisMK, Lauffenburger DA, Sorger PK. 2011. Comparing signaling networks between normal and transformed hepatocytes using discrete logical models. Cancer Res. 71:5400-11
82. Lau KS, Juchheim AM, Cavaliere KR, Philips SR, Lauffenburger DA, Haigis KM. 2011. In vivo systems analysis identifies spatial and temporal aspects of the modulation of TNF-Alpha-induced apoptosis and proliferation by MAPKs. Sci. Signal. 4:ra16
83. Hotamisligil GS. 2003. Inflammatory pathways and insulin action. Int. J. Obes. Relat. Metab. Disord. 27:S53-55
84. Hotamisligil GS. 2006. Inflammation and metabolic disorders. Nature 444:860-67
85. Pellicane JV, DeMaria EJ, Abd-Elfattah A, Reines HD, Vannice JL, Carson KW. 1993. Interleukin-1 receptor antagonist improves survival and preserves organ adenosine-5--Triphosphate after hemorrhagic shock. Surgery 114:278-84
86. Luster MI, Germolec DR, Yoshida T, Kayama F, Thompson M. 1994. Endotoxin-induced cytokine gene expression and excretion in the liver. Hepatology 19:480-88
87. Damas P, Canivet J-L, De Groote D, Vrindts Y, Albert A, et al. 1997. Sepsis and serum cytokine concentrations. Crit. Care Med. 25:405-12
88. Lalani I, Bhol K, Ahmed AR. 1997. Interleukin-10: Biology, role in inflammation and autoimmunity. Ann. Allergy Asthma Immunol. 79:469-84
89. Annacker O, Pimenta-Araujo R, Burlen-Defranoux O, Barbosa TC, Cumano A, Bandeira A. 2001. CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 166:3008-18
90. Hsueh RC, Natarajan M, Fraser I, Pond B, Liu J, et al. 2009. Deciphering signaling outcomes from a system of complex networks. Sci. Signal. 2:ra22
91. Albuszies G, Vogt J, Wachter U, Thiemermann C, Leverve X, et al. 2007. The effect of iNOS deletion on hepatic gluconeogenesis in hyperdynamic murine septic shock. Intensive Care Med. 33:1094-101
92. Zeerleder S. 2010. C1-inhibitor: More than a serine protease inhibitor. Semin. Thromb. Hemost. 37:362-74
93. Ferńandez-Śanchez A, Madrigal-Santilĺan E, Bautista M, Esquivel-Soto J, Morales-Gonźalez A, et al. 2011. Inflammation, oxidative stress, and obesity. Int. J. Mol. Sci. 12:3117-32
94. Guitton C, Cottereau A, Ǵerard N, Quillard T, Chauveau A, et al. 2010. Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: Implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases. Am. J. Physiol.: Cell Physiol. 300:C833-42
95. Lopez E, Madero L, Lopez-Pascual J, Latterich M. 2012. Clinical proteomics and OMICS clues useful in translational medicine research. Proteome Sci. 10:35
96. Rice GE, Georgiou HM, Ahmed N, Shi G, Kruppa G. 2006. Translational proteomics: Developing a predictive capacity -A review. Placenta 27(Suppl.):76-86
97. Sinha A, Singh C, Parmar D, Singh MP. 2007. Proteomics in clinical interventions: Achievements and limitations in biomarker development. Life Sci. 80:1345-54
98. Vodovotz Y, Constantine G, Faeder J, Mi Q, Rubin J, et al. 2010. Translational systems approaches to the biology of inflammation and healing. Immunopharmacol. Immunotoxicol. 32:181-276
99. SchmitzML, Weber A, Roxlau T, GaestelM, KrachtM. 2011. Signal integration, crosstalk mechanisms and networks in the function of inflammatory cytokines. Biochim. Biophys. Acta (BBA): Mol. Cell Res. 1813:2165-75
100. An G, Nieman G, Vodovotz Y. 2012. Computational and systems biology in trauma and sepsis: Current state and future perspectives. Int. J. Burns Trauma 2:1-10
101. Foteinou PT, Calvano SE, Lowry SF, Androulakis IP. 2009. Translational potential of systems-based models of inflammation. Clin. Transl. Sci. 2:85-89
102. Namas R, Zamora R, Namas R, An G, Doyle J, et al. 2012. Sepsis: Something old, something new, and a systems view. J. Crit. Care 27:314.e1-e11
103. Nieman G, BrownD, Sarkar J,Kubiak B, ZiraldoC, et al. 2012. A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit. Care Med. 40:1052-63
104. PollardHB, SrivastavaM,Eidelman O, Jozwik C, RothwellSW,et al. 2007. Proteinmicroarray platforms for clinical proteomics. Proteomics Clin. Appl. 1:934-52
105. Petricoin E, Bichsel V, Calvert V, Espina V,Winters M, et al. 2005. Mapping molecular networks using proteomics: A vision for patient-Tailored combination therapy. J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol. 23:3614-35
106. Brennan DJ, O'Connor DP, Rexhepaj E, Ponten F, GallagherWM. 2010. Antibody-based proteomics: Fast-Tracking molecular diagnostics in oncology. Nat. Rev. Cancer 10:605-17
107. Du R, Long J, Yao J, Dong Y, Yang X, et al. 2010. Subcellular quantitative proteomics reveals multiple pathway cross-Talk that coordinates specific signaling and transcriptional regulation for the early host response to LPS. J. Proteome Res. 9:1805-21